Headache

Article	Citations
Migraine treatment in pregnancy: A survey of comfort and treatment practices of women's healthcare providers	205
Virtual issue: Education in headache medicine: Insights and advancements from 2023 to 2024	91
Identifying cognitive‐affective mechanisms underlying disability in episodic migraine: Using the fear avoidance model to examine interactions	77
Evidence for increased background neural noise in migraine with aura: Hyperactive but not hyperresponsive	73
Assessing the influence of migraine on ischemic penumbra and on the prognosis of ischemic stroke: A prospective cohort study	55
Erratum	51
Drug‐resistant epicrania fugax: Responding to onabotulinumtoxinA	50
Temporary occipital nerve stimulation as transitional therapy for chronic intractable cluster headache: A case report and proof of concept	49
Response to Letter to the Editor regarding “Calcitonin gene‐related peptide and headache: Comparison of two commonly used assay kits highlights the perils of measuring neuropeptides with enzyme‐linked	48
Migraine screening in English and Spanish	46
Cortical synchronization of spontaneous trigeminal neuropathic pain monitored with in vivo optical imaging of calcium activity in freely moving mice	43
Anxiety, depression, and headache‐related disability in a large pediatric clinic–based sample	42
A retrospective analysis of the use of candesartan for migraine prevention in adolescents	40
Characteristics associated with response to subcutaneously administered anti‐CGRP monoclonal antibody medications in a real‐world community cohort of persons living with migraine: A retrospective clin	35
The impacts of migraine on functioning: Results from two qualitative studies of people living with migraine	34
Facial variant of epicrania fugax secondary to a cerebellopontine angle meningioma	32
Persistence, effectiveness, and tolerability of anti‐calcitonin gene–related peptide monoclonal antibodies in patients with chronic migraine	32
Effectiveness and acceptability of oral migraine preventives: A prospective, observational study	32
Menopausal hormone therapy, migraine history, and headache severity: Results from the Women's Health Initiative Hormone Therapy clinical trials	32
A 51‐year‐old female presenting with headache and vision loss	32
Normal glymphatic system function in patients with new daily persistent headache using diffusion tensor image analysis along the perivascular space	31
Genetic migraine disorders and the response to calcitonin gene‐related peptide antagonist treatment	31
Headache in mitochondrial diseases: From migraine to stroke‐like episodes	30
Pituitary adenylate cyclase–activating polypeptide blockade in migraine and the transformation of clinical practice	30
A 52‐week open‐label extension study to evaluate the safety and efficacy of oral rimegepant for the preventive treatment of migraine	30

Pilot study evaluating treatment with sumatriptan for moderate to severe post‐traumatic headache: A phase 2 open‐label study	29
Zavegepant and lactation: What the pharmacokinetic data suggests	27
Long‐term efficacy and safety of erenumab in patients with chronic migraine and acute medication overuse: A subgroup analysis	27
Headache and psychological variables as predictors of disability in individuals with primary headache disorders	27
Routine migraine screening as a standard of care for Women's health: A position statement from the American Headache Society	27
Dietary sodium and headache are linked by cerebrospinal fluid sodium concentration to sodium‐specific appetite, tolerance, and perceptive reward	26
The teaching of headache medicine in France: A questionnaire‐based study	26
Index	25
Developing and delivering a migraine disparities and diagnosis undergraduate medical educational program to underrepresented in medicine medical student members of the Student National Medical Associa	24
Patient headache questionnaires can improve headache diagnosis and treatment in children	24
Sequential administration of peripheral nerve blocks and  onabotulinumtoxinA for the treatment of chronic migraine and other headache disorders—A ret	24
Neuromodulation for primary headache disorders: Advantages and challenges	23
Effect of erenumab versus other migraine preventive medications on cardiovascular and cerebrovascular outcomes: A United States claims database‐based observational cohort study	23
A retrospective review of sex differences of white matter hyperintensities in brain MRI of patients with migraine	23
Effects of fremanezumab on migraine‐associated symptoms and medication use in Japanese and Korean patients with episodic migraine: Exploratory endpoint analysis of a multicenter, randomized, double‐bl	23
Response to: Calcitonin gene‐related peptide and headache: Comparison of two commonly used assay kits highlights the perils of measuring neuropeptides with enzyme‐linked immunosorbent assays	23
Patient‐reported experiences with migraine‐related cognitive symptoms: Results of the MiCOAS qualitative study	22
In Memoriam—Doctor J. Keith Campbell	22
TRPM3 activation causes CGRP release in trigeminal neurons: Implications for migraine mechanisms	22
New academic year in Headache	21
Prevalence of primary stabbing headache: A meta‐analysis	21
Patients with chronic post‐dural puncture headache do not have typical imaging features of intracranial hypotension: An MRI study using the Bern scor	21
CCH attack frequency reduction after psilocybin correlates with hypothalamic functional connectivity	21
Issue Information	20
Chronotype and primary headaches: What a population‐based study reveals	20
The elephant in the room: How the underfunding of headache research stunts the field	20
	19
Treatment effectiveness of galcanezumab versus traditional oral migraine preventive medications at 3 months: Results from the TRIUMPH study	19
Dystonia phenomenology and treatment response in migraine	19
OnabotulinumtoxinA as a promising treatment for primary trochlear headache: A retrospective case series	19
The 2024 Headache editorial board Conflict of Interest Declarations	18
Challenges and opportunities for estimating and assessing migraine prevalence, incidence and impact across study populations and methodologies: Bridging global and United Stat	18
Issue Information	18
Issue Information	18
Assessing blood pressure changes and hypertension‐related outcomes in patients with migraine treated with erenumab: A systematic review and meta‐analysis	18
Intravenous magnesium and methocarbamol for acute pain crises in refractory trigeminal neuralgia: A retrospective analysis	17
Post‐vaccination headache reporting: Trends according to the Vaccine Adverse Events Reporting System	17
Engagement and predictors of use of a smartphone app for migraine self‐management: A secondary analysis of the EMMA trial	17
Socioeconomic and geographic inequalities in headache disability in Brazil: The 2019 National Health Survey	17
Changes in cognitive appraisal in a randomized controlled trial of mindfulness‐based cognitive therapy for patients with migraine	16
Sustained benefits of onabotulinumtoxinA treatment in chronic migraine: An analysis of the pooled Phase 3 REsearch Evaluating Migraine Prophylaxis Therapy (PREEMPT) randomized controlled trials	16
Alcohol as a trigger of migraine attacks in people with migraine. Results from a large prospective cohort study in English‐speaking countries	16
Rates and healthcare resource utilization for people with branded acute and preventive migraine prescription medication order payer denials: An open, multi‐source dataset, observational cohort study	16
Headache and acute cerebrovascular disease: How do we differentiate primary and secondary headache disorders in the emergency setting?	16
A phase 1 study of the breast milk and plasma pharmacokinetics of zavegepant 10 mg intranasal dose in healthy lactating women	16
Evaluation of vascular risk in patients with migraine with and without aura treated with erenumab: Post hoc analysis of pooled long‐term clinical trial data	16
Remote electrical neuromodulation to treat children and adolescents with migraine in the emergency department: A randomized double‐dummy pilot trial	16
Recurrent painful ophthalmoplegic neuropathy with headache and oculomotor palsy 18 years apart	16
Afterimage duration differs for migraine with or without aura	15
A large language model–based generative natural language processing framework fine‐tuned on clinical notes accurately extracts headache frequency from electronic health records	15

Plain Language Summary Publication: Investigating the causal and genetic relationship between migraine and Parkinson’s disease	15
Prediction of individual trigeminal pain sensitivity from gray matter structure within the sensorimotor network	15
Issue Information	15
Prevalence, characteristics, and factors associated with caffeine‐withdrawal headache during the first day of Ramadan	15
Validation of a Portuguese version of the four‐item Migraine Interictal Burden Scale	15
The 2025 Headache Editorial Board conflict of interest declarations	14
	14
Issue Information	14
Different dosage regimens of erenumab for the treatment of migraine: A systematic review and meta‐analysis of the efficacy and safety of randomized controlled trials	14
Burden of migraine in Brazil: A cross‐sectional real‐world study	14
The cortical spreading depression/migraine aura hypothesis – Finally some definitive evidence	13
Development and pharmacological characterization of novel multi‐ calcitonin gene‐related peptide and pituitary adenylate cyclase‐activating peptide receptor antagonists	13
Emergency department utilization among patients who receive outpatient specialty care for headache: A retrospective cohort study analysis	13
Challenges in the management of new daily persistent headache at a tertiary headache center—A retrospective real‐world evidence study	13
Chronotype in migraine and tension‐type headache: A population study	13
Reversible cerebral vasoconstriction syndrome: A narrative review	13
Melatonin for migraine prevention in children and adolescents: A randomized, double‐blind, placebo‐controlled trial after single‐blind placebo lead‐in	13
	13
Remote electrical neuromodulation for reducing procedural pain in patients with chronic migraine receiving onabotulinumtoxinA injections: A randomize	13
Lifestyle triggers of migraine: Sleep restriction and caffeine lower the threshold for migraine‐like responses in rats in a sex‐specific manner	12
Headache in individuals undergoing hormone therapy for gender transition: A cross‐sectional, observational study	12
Plain Language Summary Publication: The 2023 protocol for update to acute treatment of adults with migraine in the emergency department: The American headache society evidence assessment of parenteral	12
Clinical characteristics and patient‐reported outcomes of chronic and episodic migraine patients at a US tertiary headache center: A retrospective observational study	12
Plasma calcitonin gene–related peptide and nerve growth factor as headache and pain biomarkers in recently deployed soldiers with and without a recent concussion	12
Clinical factors associated with day‐to‐day peak pain severity in individuals with chronic migraine: A cohort study using daily prospective diary data	12
Eicosapentaenoic acid versus placebo as adjunctive therapy in chronic migraine: A randomized controlled trial	12
American Headache Society 68th Annual Scientific Meeting June 4–7, 2026, Orlando, Florida	12
Issue Information	12
Decision‐making impairment under ambiguity but not under risk may underlie medication overuse in patients with chronic migraine	12
Effect of galcanezumab in women with episodic migraine meeting criteria for menstrually related migraine: A post hoc analysis of EVOLVE ‐1 and	12
Basic Science Prize Award 2024	12
Factors associated with efficacy of occipital nerve stimulation in medically intractable chronic cluster headache	12
Beyond aura: Understanding migraine as a cycling pan‐sensory threshold disease	12
Zavegepant nasal spray for the acute treatment of migraine: A Phase 2/3 double‐blind, randomized, placebo‐controlled, dose‐ranging trial	11
Long‐term effectiveness of eptinezumab in the treatment of patients with chronic migraine and medication‐overuse headache	11
Letters from nobody: The problem of AI ‐written Letters to the Editor	11
Essential but often overlooked reporting elements for Headache manuscripts	11
Arterial hypertension: A safety risk of calcitonin gene‐related peptide ligand and receptor blocker class	11
Characterization of trigeminal C‐fiber reactivity through capsaicin‐induced release of calcitonin gene‐related peptide	11
Treatment of abdominal migraine in an 8‐year‐old child with calcitonin gene‐related peptide receptor antagonist: A case report	11
Digital headache self‐management interventions for patients with a primary headache disorder: A systematic review of randomized controlled trials	11
Efficacy and safety of rimegepant for the acute treatment of migraine in Japan: A dose‐ranging, double‐blind, randomized controlled trial	11
Predictive factors of epidural blood patch success in intracranial hypotension syndrome	11
Issue Information	11
Arachnoid granulations in idiopathic intracranial hypertension: Do they have an influence?	11
Secondary nummular headache: Are they more common than we thought?	11
Visual hypersensitivity in patients treated with anti‐calcitonin gene–related peptide (receptor) monoclonal antibodies	10
Response to: Disagreement with Categorization of Clinical Trials included in Treadwell et al. Systematic Review and Meta‐Analysis	10
Headache in transgender men using gender‐affirming hormone therapy: A case–control study	10
The impact of updates in headache quality measures on adherence to best practices in a neurology resident clinic: A quality improvement study	10
Correction to “Smartphone‐delivered progressive muscle relaxation for the treatment of migraine in primary care: A randomized controlled trial”	10
Improving distress perception and mutuality in migraine caregivers after 6 months of galcanezumab treatment	10
The pathogenic role of calcitonin gene‐related peptide and predictors of new‐onset migraine and long‐term outcomes after transcatheter atrial septal defect closure	10
The link between reversible cerebral vasoconstriction syndrome and transient global amnesia	10
Causal associations between genetically predicted placental weight and migraine	10
Post hoc analysis of clinical trial data and pharmacokinetic data to assess wearing‐off of erenumab within monthly treatment cycle	10
Time to reconsider the association between migraine and white matter hyperintensities?	10
Exploring the impact of acute SARS‐CoV‐2 infection on headache pattern in patients with migraine: A novel Bayesian analysis	10
Migraine epidemiology in collegiate student‐athletes: Findings from the Concussion Assessment, Research, and Education (CARE) Consortium	10
Plain Language Summary Publication: Evaluating the use of paracetamol to prevent fasting headache during the first week of Ramadan: A randomized, open‐label, clinical trial	10
	10
Effect of wildfire smoke on primary headache disorders remains unclear	10
Issue Information	10
Insomnia severity in migraine: The role of headache frequency, aura status, and comorbidities—A cross‐sectional study	10
Mechanisms of change in posttraumatic headache–related disability: A mediation model	10
Glial activation in pain and emotional processing regions in the nitroglycerin mouse model of chronic migraine	10
Counting the cost: How migraine shapes lives and economies	9
Migraine in the context of chronic primary pain, chronic overlapping pain disorders, and functional somatic disorders: A narrative review	9
Magnetoencephalography studies in migraine and headache disorders: A systematic review	9
Beyond movement: Headache in patients with functional movement disorders	9
	9
The importance of patient and family perspectives of clinical decisions in pediatric headache	9
Issue Information	9
Is headache always necessary for the diagnosis of rebound intracranial hypertension in patients successfully treated for cerebrospinal fluid venous fistula?	9
Validity of self‐reported migraine in adolescents and children	9
2025 guideline update to acute treatment of migraine for adults in the emergency department: The American Headache Society evidence assessment of parenteral pharmacotherapies	9
Celebrating Headache 's 2023 graduating class of Assistant Editors	9
Migraine, idiopathic intracranial hypertension, and calcitonin gene‐related peptide antibodies	9
Cluster Analysis of Migraine‐associated Symptoms (CAMS) in youth: A retrospective cross‐sectional multicenter study	9
Migraine and infertility, merging concepts in women's reproductive health: A narrative review	9

Effectiveness of galcanezumab versus topiramate, amitriptyline, and other select traditional oral migraine preventives with evidence of efficacy: 3‐Month results from the TRIU	9
Headache diagnosis and treatment: A pilot knowledge and needs assessment among physical therapists	9
The effectiveness of parenteral agents for pain reduction in patients with migraine presenting to emergency settings: A systematic review and network analysis	8
Issue Information	8
A post hoc analysis of migraine‐associated symptoms from the phase 3 randomized, double‐blind, sham‐controlled Trial of External trigeminal nerve stimulation for the Acute treatment of Migraine (	8
Long‐term evolution of white and gray matter structural properties in migraine	8
Cervical musculoskeletal function is variable in tension‐type headache: A cluster analysis	8
Identifying and predicting headache trajectories among those with acute post‐traumatic headache	8
Circadian functional changes of pain‐processing brainstem nuclei and implications for cluster headache: A 7 Tesla imaging study	8
Symptomatic visual snow in acute ischemic stroke: A case series	8
Author Index	8
Heavy metal and trace element alterations in patients during a migraine attack	8
Electroretinography and pupillary response in migraine	8
The association between posttraumatic stress disorder and migraine: A systematic review	8
Letter to the Editor regarding “Impact of perilesional edema on severity of migraine in patients with calcified neurocysticercosis: A prospective evaluation”	8
The status of status migrainosus: Exploring conceptual and operational limitations of International Classification of Headache Disorders criteria	8
Patient headache questionnaires can improve headache diagnosis and treatment in children	8
A unifying disease model of idiopathic intracranial hypertension: A narrative review	8
Effectiveness and tolerability of galcanezumab for migraine prevention in patients ≥65 years: A real‐life multicenter study	8
The 15‐day threshold in the definition of chronic migraine is reasonable and sufficient—Five reasons for not changing the ICHD‐3 definition	7
Trainee highlights	7
Epidemiology and characteristics of status migrainosus in a tertiary headache clinic: A retrospective cohort study	7
Preliminary exploration of a multidimensional sleep health composite in adolescent females with frequent migraine	7
Comparative prevalence and characteristics of fabricated citations in large language models in headache medicine	7
Efficacy and safety of rimegepant for the acute treatment of migraine in Black or African American adults: A post hoc pooled subgroup analysis from three randomized, placebo‐controlled clinical trials	7
Cerebrovascular reactivity to hypercapnia in patients with migraine: A dual‐echo arterial spin labeling MRI study	7
American Headache Society 67th Annual Scientific Meeting June 19–22, 2025 Minneapolis, Minnesota	7
A patient‐centered conceptual model and measurement framework for migraine experience developed by the Migraine Clinical Outcome Assessment System	7
Correction to “A causative role for remote dural puncture and resultant arachnoid bleb in new daily persistent headache: A case report”	7
Neuropathic changes in corneal nerve endings—A potential objective biomarker for migraine frequency and response to treatment	7
	7
	7
A critical appraisal of the International Classification of Headache Disorders migraine diagnostic criteria based on a retrospective multicenter cross‐sectional headache registry study in youth	7
Real‐world barriers to health care utilization among people living with migraine: Insights from the All of Us Research Program	7
Online interest in calcitonin gene‐related peptide‐therapies: An infodemiology study using Google trends	7
Biochemical profiling and symptomatology of androgen deficiency in males with cluster headache: A prospective case–control study	7
Indomethacin‐responsive idiopathic red ear syndrome: A pediatric case	7
	7
Insight of a headache medicine provider in Indian Health Service: A personal and professional observation	7
Welcoming Headache 's 2024 incoming class of Assistant Editors	7
Healthcare costs and resource utilization in patients with migraine treated with erenumab: A retrospective, non‐interventional study using claims data from the United States	7
Machine learning models and classification algorithms in the diagnosis of vestibular migraine: A systematic review and meta‐analysis	7
The Chronic Headache Self‐Efficacy Scale: Development and assessment of measurement properties	7
Bridging old and new: The 2026 American Headache Society Annual Scientific Meeting	7
Exploratory investigation of a patient‐informed low‐dose psilocybin pulse regimen in the suppression of cluster headache: Results from a randomized, double‐blind, placebo‐controlled trial	7
Virtual issue: Recent advances in pediatric headache: Bridging the data gap	7
Good News? Bad News? Idiopathic intracranial hypertension and migraine	6
Pain medication beliefs in individuals with headache	6
Habitual caffeinated beverage consumption and headaches among adults with episodic migraine: A prospective cohort study	6
Sustained response of galcanezumab in migraine prevention: Patient‐level data from a post hoc analysis in patients with episodic or chronic migraine	6
Cost per treatment responder analysis of atogepant compared to rimegepant for the preventive treatment of episodic migraine	6
Issue Information	6
Multi‐region local field potential signatures and brain coherence alternations in response to nitroglycerin‐induced migraine attacks	6
Learning headache triggers through experience: A laboratory study	6
Blood serum levels of PACAP and migraine onset: A systematic review and meta‐analysis of observational studies	6
Investigating the effects of weather on headache occurrence using a smartphone application and artificial intelligence: A retrospective observational cross‐sectional study	6
Heightened migraine risk in patients with rheumatoid arthritis: A national retrospective cohort study	6
A study of migraine‐like headache caused by topical aryl hydrocarbon receptor agonist tapinarof	6
Trainee highlights	6
A qualitative evidence synthesis of patient perspectives on migraine treatment features and outcomes	6
Long‐term reductions in acute headache medication use after eptinezumab treatment in patients with migraine and prior preventive treatment failures: Post hoc analysis of the D	6
Editorial: Migraine as a marker of maternal morbidity	6
Nummular headache responsive to suzetrigine, a novel, selective sodium channel antagonist	6
Efficacy of galcanezumab in proline‐rich transmembrane protein 2 ( PRRT2 )	6
Headache launches the publication of plain language summaries	6
Case report: Treatment of temporomandibular joint disorder pain with V3 nerve block procedure	6
Ramadan fasting in smokers with primary headache disorders: Impact of nicotine dependence on headache frequency and severity	6
A multicenter, randomized, double‐blind, placebo‐controlled, crossover trial to evaluate the efficacy and safety of zolmitriptan nasal spray for the acute treatment of migraine in patients aged 6 to 1	6
Evaluating associations of migraine‐related vertigo	6
Baseline factors associated with post‐stenting intracranial pressure in patients with idiopathic intracranial hypertension with venous sinus stenosis	6
Hemicrania continua exacerbations with prodromal burping as a potential autonomic symptom	6
Plain Language Summary Publication: Regulation of headache response and transcriptomic network by the trigeminal ganglion clock	6
Potential drug interaction between calcitonin gene‐related peptide antagonists and neonatal Fc receptor inhibitors	6
Study participant impression of use and satisfaction with STS101 (dihydroergotamine nasal powder): Results from the open‐label ASCEND acute migraine study	6
Patient preferences for preventive migraine treatments among Canadian adults: A discrete choice experiment	6
A multicenter, prospective, single‐arm study of 60‐day peripheral nerve stimulation of the occipital nerves for the treatment of headache	6
Acute migraine treatments in patients above age 65	6
Issue Information	6
Sex influences the progression of cephalic mechanical and light hypersensitivities in a mouse model of chronic migraine	6
Sex‐specific differences in the relationship between AHA Life's Essential 8 factors and migraine disorders: A cross‐sectional evaluation in	6
A placebo controlled, randomized clinical trial of galcanezumab for vestibular migraine: The INVESTMENT study	6
Phenotype of midfacial pain in 12 new cases—A multidisciplinary idiopathic facial pain syndrome	6
The impact of fear of attacks on pain‐related disability in cluster headache: Insights from the fear avoidance model	6
Comfort matters: A new strategy to ease injection pain during headache treatment procedures	6
Efficacy of an educational website on headaches in schoolchildren: A cluster‐randomized controlled trial	6
IV dexamethasone as adjuvant therapy to metoclopramide for acute posttraumatic headache in the ED : A randomized contr	6
The complex relationship between alcohol and migraine	6
Retrofitted adult interventions aren't good enough: Why children and adolescents deserve tailored evidence‐based care for migraine in the emergency department	5
Circannual worsening in cluster headache correlates with daylight change	5
In reply to: “Glymphatic dysfunction is unlikely to cause idiopathic intracranial hypertension”	5
Cardiovascular risk and triptan usage among patients with migraine	5
Author response to comments on our article “Impact of perilesional edema on severity of migraine in patients with calcified neurocysticercosis: A prospective evaluation”	5
Plain Language Summary Publication: Reversible cerebral vasoconstriction syndrome: A narrative review	5
Mechanisms for mindfulness in migraine: Does catastrophizing matter?	5
In Memoriam: Neil Raskin MD , FAHS , FAAN (1935	5